You must be a subscriber to see the full results of your search.
Please log in or subscribe below if you are not already a subscriber.
The Daily News subscribers get full access to more than
13
million names and addresses along with powerful search and download features.
Get the business leads you need with powerful searches of public records and notices.
Download listings into your spreadsheet or database.
Learn more about our services
| Search again
Editorial Results (free)
1.
Steiner, GTx Inc. Prepare For Next Step of Journey -
Monday, April 16, 2012
Dr. Mitchell Steiner recently returned from a trip to Eastern Europe, where he visited hospitals participating in international clinical trials for the drug enobosarm, which is being developed by his Memphis-based public biopharmaceutical company GTx Inc.
2.
Many Questions Raised Before Going Public -
Monday, April 16, 2012
As Facebook prepares for its multibillion-dollar initial public offering (IPO) next month, it sheds light on how companies – including local ones – decide whether to go public or not.
Memphis-based pharmaceutical company GTx Inc. went public in 2004 and local paper producer Verso Paper Corp. held its IPO in 2008, but the overall number of publicly traded companies both locally and nationally has dropped over the past two decades.
3.
GTx’s Loss Widens on News of Abandoned Drug -
Tuesday, August 10, 2010
The write-off of investments related to the development of a drug that didn’t pan out caused GTx Inc. to have a bigger loss during the second quarter.
4.
GTx’s Loss Widens on News of Abandoned Drug -
Monday, August 09, 2010
The write-off of investments related to the development of a drug that didn’t pan out caused GTx Inc. to have a bigger loss during the second quarter.
5.
Powerful Possibilities -
Monday, May 17, 2010
Oct. 29 turned into a day for window staring when the news came.
The top executives of GTx Inc. looked at the bleak gray of an overcast sky from the seventh floor of the Toyota Center, their minds gone blank.
6.
GTx Reports $44.3M Net Income -
Wednesday, May 05, 2010
GTx Inc. is pressing ahead with the development of a drug for muscle wasting in cancer patients after ending its partnership with Merck.
7.
GTx, Merck Part Ways -
Tuesday, March 16, 2010
Memphis-based GTx Inc. has ended its partnership with Merck & Co. to develop a drug to prevent wasting and muscle loss in cancer patients.
8.
Influence 1 Foundation Names Hartsfield COO -
Wednesday, February 11, 2009
Felicia Hartsfield has been named chief operating officer of Influence 1 Foundation.
Hartsfield will oversee the continued stability and growth of the foundation’s fiscal, strategic, organizational and operational functions. Her duties also will include building and maintaining relationships with community leaders, as well as creating collaborations, which will enhance the foundation’s strategic model.
9.
GTx Outlines Drug Pipeline -
Friday, November 07, 2008
Executives at Memphis-based GTx on Thursday morning explained a promising pipeline of potential drug therapies that are moving closer to FDA approval and attracting investment partnerships from big pharmaceutical companies.
10.
Burford to Help Develop PR Efforts For Memphis Area Teachers' Credit Union -
Wednesday, June 14, 2006
Marc Burford has been promoted to business development coordinator at Memphis Area Teachers' Credit Union (MATCU). In his new role, Burford will be responsible for helping develop public relations and for coordinating various public functions that promote MATCU's products and services. He started working at MATCU in 2003 as a sales associate and was promoted to an assistant branch manager in 2004.